Carboplatin response in preclinical models for ovarian cancer: comparison of 2D monolayers, spheroids, ex vivo tumors and in vivo modelsMelica Nourmoussavi Brodeur, Anne‐Marie Mes‐Masson|Scientific Reports|2021Cited by 49
Interferon response and epigenetic modulation by <i>SMARCA4</i> mutations drive ovarian tumor immunogenicityMelica Nourmoussavi Brodeur, Dmitriy Zamarin|Science Advances|2024Cited by 9